SCHEMBL4586935

SCHEMBL4586935

C=CCCCCCCCCCc1cc(C)ccc1S(=O)(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
EP300 Q09472 1/20 0.34
KAT2B Q92831 1/20 0.34
KAT5 Q92993 1/20 0.34
KAT8 Q9H7Z6 1/20 0.34
MEP1B Q16820 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
MAPK1 P28482 1/20 0.32
HDAC1 Q13547 2/20 0.32
GAA P10253 2/20 0.32
HSD17B10 Q99714 1/20 0.32
MPL P40238 1/20 0.32
HDAC4 P56524 1/20 0.32
LMNA P02545 2/20 0.31
PSMB5 P28074 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9878598 1.00 ALDH1A1 (0.34) ALDH1A1HPGDUSP2TDP1EP300
SCHEMBL6819883 0.99 MEP1B (0.33) ALDH1A1HPGDUSP2TDP1EP300
SCHEMBL11332776 0.89 ALDH1A1 (0.36) ALDH1A1HPGDUSP2TDP1EP300
SCHEMBL8020739 0.88 GAA (0.35) ALDH1A1HPGDTDP1MEP1BL3MBTL1
SCHEMBL5718660 0.88 GAA (0.38) ALDH1A1HPGDTDP1MEP1BL3MBTL1
SCHEMBL8086471 0.88 GAA (0.38) ALDH1A1HPGDTDP1MEP1BL3MBTL1
SCHEMBL8084853 0.88 GAA (0.38) ALDH1A1HPGDTDP1MEP1BL3MBTL1
SCHEMBL5718608 0.88 GAA (0.38) ALDH1A1HPGDTDP1MEP1BL3MBTL1
SCHEMBL8082255 0.88 GAA (0.38) ALDH1A1HPGDTDP1MEP1BL3MBTL1
SCHEMBL8084715 0.88 GAA (0.38) ALDH1A1HPGDTDP1MEP1BL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2679322-B1 PARTICLE AGGREGATE, MANUFACTURING METHOD FOR PARTICLE AGGREGATE, FLUORESCENCE ENHANCING ELEMENT, AND DEVICE USING PHOTOCHEMICAL REACTIONS UNIV HOKKAIDO NAT UNIV CORP (JP) 2019-02-06 EP disclosed
US-9447316-B2 Particle aggregate, manufacturing method for particle aggregate, fluorescence enhancing element, and device using photochemical reactions NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2016-09-20 US disclosed
US-20140077132-A1 Particle Aggregate, Manufacturing Method for Particle Aggregate, Fluorescence Enhancing Element, and Device Using Photochemical Reactions National University Corporation,HokkaidoUniversity (JP) 2014-03-20 US disclosed
EP-2679322-A1 PARTICLE AGGREGATE, MANUFACTURING METHOD FOR PARTICLE AGGREGATE, FLUORESCENCE ENHANCING ELEMENT, AND DEVICE USING PHOTOCHEMICAL REACTIONS National University Corporation Hokkaido University (JP) 2014-01-01 EP disclosed
US-20080206103-A1 Method For The Preparation Of Very Stable, Self-Assembled Monolayers On The Surface Of Gold Coated Microcantilevers For Application To Chemical Sensing UT-BATTELLE, LLC (US) 2008-08-28 US disclosed
EP-1794580-A2 SELF-ASSEMBLED MONOLAYERS ON THE SURFACE OF GOLD COATED MICROCANTILEVERS FOR APPLICATION TO CHEMICAL SENSING AND METHOD OF PREPARATION UT-Battelle, LLC (US) 2007-06-13 EP disclosed
WO-2006031846-A2 SELF-ASSEMBLED MONOLAYERS ON THE SURFACE OF GOLD COATED MICROCANTILEVERS FOR APPLICATION TO CHEMICAL SENSING AND METHOD OF OPERATION UT-BATTELLE, LLC (US) 2006-03-23 WO disclosed
US-6576335-B2 Used to replace the costly and toxic solvent extraction steps of conventional copper processing; preferential; for recovering copper from aqueous solutions in the copper mining and copper plating industries BECHTEL BWXT IDAHO, LLC 2003-06-10 US disclosed
US-20020114961-A1 Solid-phase materials for chelating metal ions and methods of making and using same BECHTEL BWTX IDAHO, LLC 2002-08-22 US disclosed
EP-0653429-B1 New silanes and their use in silylation of dielectric materials HOFFMANN LA ROCHE (CH) 2001-06-13 EP disclosed
EP-0653429-A1 Silanes and their use in silylation of dielectric materials F. HOFFMANN-LA ROCHE AG (CH) 1995-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080206103-A1 Method For The Preparation Of Very Stable, Self-Assembled Monolayers On The Surface Of Gold Coated Microcantilevers For Application To Chemical Sensing CALU, CALR, CALD1 ALDH1A1 1504/4885HPGD 888/4885USP2 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.